BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$156M |
| 2 |
SPDR Gold Trust
GLD
|
+$142M |
| 3 |
Bank of America
BAC
|
+$107M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$92.9M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.53B |
| 2 |
Equinix
EQIX
|
+$2B |
| 3 |
Gilead Sciences
GILD
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.48B |
| 5 |
United Therapeutics
UTHR
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.55% |
| 2 | Technology | 24.39% |
| 3 | Consumer Discretionary | 8.23% |
| 4 | Materials | 5.85% |
| 5 | Real Estate | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
2351
DELISTED
Wright Medical Group Inc
WMGI
| $16.1K | ﹤0.01% |
523
-10,604
| -95% | -$300K |
|
|
GEVA
2352
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $16.1K | ﹤0.01% |
248
-4,461
| -95% | -$265K |
|
2353
Stepan Co
SCL
$1.48B
| $16K | ﹤0.01% |
244
-4,910
| -95% | -$300K |
|
2354
G-III Apparel Group
GIII
$1.43B
| $16K | ﹤0.01% |
434
-8,802
| -95% | -$264K |
|
|
AAWW
2355
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $15.9K | ﹤0.01% |
387
-6,777
| -95% | -$277K |
|
|
DFS
2356
PUT
DELISTED
Discover Financial Services
DFS
| $15.9K | ﹤0.01% |
+3,066
| New | +$161K |
|
2357
Churchill Downs
CHDN
$6.33B
| $15.9K | ﹤0.01% |
1,062
-20,994
| -95% | -$305K |
|
2358
Geospace Technologies
GEOS
$72.4M
| $15.8K | ﹤0.01% |
167
-3,354
| -95% | -$308K |
|
|
TYPE
2359
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $15.8K | ﹤0.01% |
495
-10,045
| -95% | -$293K |
|
2360
Caleres
CAL
$449M
| $15.8K | ﹤0.01% |
560
-11,081
| -95% | -$271K |
|
|
GK
2361
DELISTED
G&K Services Inc
GK
| $15.7K | ﹤0.01% |
253
-5,035
| -95% | -$304K |
|
2362
Protolabs
PRLB
$2.18B
| $15.7K | ﹤0.01% |
221
-4,480
| -95% | -$347K |
|
2363
CALL
Boston Properties
BXP
$10.9B
| $15.7K | ﹤0.01% |
1,925
| – | – |
|
|
MDAS
2364
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $15.7K | ﹤0.01% |
790
-15,731
| -95% | -$354K |
|
|
SUSS
2365
DELISTED
SUSSER HOLDINGS CORPORATION COMMON STOCK
SUSS
| $15.7K | ﹤0.01% |
239
-4,803
| -95% | -$284K |
|
2366
CALL
Biogen
BIIB
$31B
| $15.6K | ﹤0.01% |
23
-67
| -74% | -$17.3K |
|
2367
Kopin
KOPN
$998M
| $15.6K | ﹤0.01% |
3,706
-14,700
| -80% | -$56.5K |
|
|
KEG
2368
DELISTED
KEY ENERGY SERVICES INC
KEG
| $15.6K | ﹤0.01% |
1,976
-39,993
| -95% | -$316K |
|
2369
Enpro
NPO
$7.25B
| $15.5K | ﹤0.01% |
269
-5,511
| -95% | -$316K |
|
|
MAGN
2370
Magnera Corp
MAGN
$439M
| $15.5K | ﹤0.01% |
43
-871
| -95% | -$309K |
|
|
MANT
2371
DELISTED
Mantech International Corp
MANT
| $15.5K | ﹤0.01% |
+517
| New | +$14.8K |
|
|
PMCS
2372
DELISTED
P M C SIERRA INC
PMCS
| $15.4K | ﹤0.01% |
2,398
-53,856
| -96% | -$334K |
|
2373
RH
RH
$3.45B
| $15.4K | ﹤0.01% |
229
-4,642
| -95% | -$318K |
|
|
CMD
2374
DELISTED
Cantel Medical Corporation
CMD
| $15.4K | ﹤0.01% |
454
-8,626
| -95% | -$299K |
|
|
ACOR
2375
DELISTED
Acorda Therapeutics
ACOR
| $15.4K | ﹤0.01% |
4
-89
| -96% | -$347K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2013 Portfolio in Review
As of Q4 2013, BNP Paribas Financial Markets held 4,298 positions worth $137B, down 0.25% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
BNP Paribas Financial Markets withdrew a net $60.2B in Q4 2013, closing 193 positions and reducing 1,811 holdings. Its most notable exit was Innoviva, an estimated $182M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, BNP Paribas Financial Markets opened a new position in Ambev worth $22.5M.
- BNP Paribas Financial Markets's largest Q4 2013 buy was Ambev: 3,066,560 shares worth $22.5M.
- BNP Paribas Financial Markets added most to Apple in Q4 2013, an estimated $156M increase.
- BNP Paribas Financial Markets's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53B.
- BNP Paribas Financial Markets fully exited Innoviva in Q4 2013, selling an estimated $182M.
- BNP Paribas Financial Markets's ten largest holdings make up 38% of its $137B portfolio in Q4 2013.
- BNP Paribas Financial Markets opened 1,712 new positions and closed 193 in Q4 2013.
- BNP Paribas Financial Markets's portfolio value fell 0.25% quarter-over-quarter to $137B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.